))
Setting Up a Robust CGT Supply Chain (Part 2)
Manage episode 435605126 series 3554424
Content provided by Quick Group of Companies. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Quick Group of Companies or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Today we continue our conversation with Mike Sweeney, Global Head of Strategy for Cell & Gene Therapies and Direct to Patient products at QuickSTAT Global Life Science Logistics, on how to set up a robust CGT supply chain.
In Part 1, Mike described the explosion of cell and gene therapies registered for clinical trials – plus the hope and supply chain logistics challenges that growth provides.
In Part 2, Mike discusses the benefits of advanced planning, the role of technology, as well as cold chain and chain of custody. We began, however, with his analysis of the ongoing regulatory change globally. I asked Mike: How does QuickSTAT stay on top of it, and what type of guidance do they give?
8 episodes
Share
